A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
Titel:
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer
Auteur:
Cristofanilli, Massimo Johnston, Stephen R. D. Manikhas, Alexey Gomez, Henry L. Gladkov, Oleg Shao, Zhimin Safina, Sufia Blackwell, Kimberly L. Alvarez, Ricardo H. Rubin, Stephen D. Ranganathan, Sulabha Redhu, Suman Trudeau, Maureen E.